These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616 [TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286 [TBL] [Abstract][Full Text] [Related]
5. [Peripartum Cardiomyopathy]. Pfeffer TJ; König T; Berliner D; Bauersachs J Dtsch Med Wochenschr; 2022 Nov; 147(23):1537-1544. PubMed ID: 36384155 [TBL] [Abstract][Full Text] [Related]
6. Peripartum cardiomyopathy in patients with psychiatric disorders successfully treated with bromocriptine: Two case reports. Takanaka H; Ono R; Kato H; Iwahana T; Miyahara T; Takahashi H; Hori Y; Fukushima K; Kobayashi Y J Cardiol Cases; 2024 Mar; 29(3):136-139. PubMed ID: 38481642 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of bromocriptine treatment in a patient with peripartum cardiomyopathy. Ichida M; Katsurada K; Komori T; Matsumoto J; Ohkuchi A; Izumi A; Matsubara S; Mitsuhashi T; Kario K J Cardiol Cases; 2010 Aug; 2(1):e28-e31. PubMed ID: 30546703 [TBL] [Abstract][Full Text] [Related]
8. Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy. Horn P; Saeed D; Akhyari P; Hilfiker-Kleiner D; Kelm M; Westenfeld R ESC Heart Fail; 2017 Nov; 4(4):641-644. PubMed ID: 28744986 [TBL] [Abstract][Full Text] [Related]
9. Bromocriptine for the Treatment of Peripartum Cardiomyopathy. Koenig T; Bauersachs J; Hilfiker-Kleiner D Card Fail Rev; 2018 May; 4(1):46-49. PubMed ID: 29892477 [TBL] [Abstract][Full Text] [Related]
10. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy. Hilfiker-Kleiner D; Struman I; Hoch M; Podewski E; Sliwa K Curr Heart Fail Rep; 2012 Sep; 9(3):174-82. PubMed ID: 22729360 [TBL] [Abstract][Full Text] [Related]
12. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies. Ricke-Hoch M; Pfeffer TJ; Hilfiker-Kleiner D Cardiovasc Res; 2020 Mar; 116(3):520-531. PubMed ID: 31605117 [TBL] [Abstract][Full Text] [Related]
13. Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review. Chinweuba GC; Rutkofsky IH Cureus; 2020 Oct; 12(10):e10790. PubMed ID: 33042652 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found. Kryczka KE; Demkow M; Dzielińska Z Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254703 [TBL] [Abstract][Full Text] [Related]
16. Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature. Caruso G; Scopelliti A; Scaramuzzino S; Perrone G; Galoppi P; Palaia I; Muzii L; Panici PB; Brunelli R Case Rep Womens Health; 2021 Jan; 29():e00277. PubMed ID: 33344177 [TBL] [Abstract][Full Text] [Related]
17. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Ricke-Hoch M; Bultmann I; Stapel B; Condorelli G; Rinas U; Sliwa K; Scherr M; Hilfiker-Kleiner D Cardiovasc Res; 2014 Mar; 101(4):587-96. PubMed ID: 24448315 [TBL] [Abstract][Full Text] [Related]